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Abstract
Background: Preimplantation development is a crucial step in early human development. However, the molecular basis of
human preimplantation development is not well known.
Methodology: By applying microarray on 397 human oocytes and embryos at six developmental stages, we studied the
transcription dynamics during human preimplantation development.
Principal Findings: We found that the preimplantation development consisted of two main transitions: from metaphase-II
oocyte to 4-cell embryo where mainly the maternal genes were expressed, and from 8-cell embryo to blastocyst with down-
regulation of the maternal genes and up-regulation of embryonic genes. Human preimplantation development proved
relatively autonomous. Genes predominantly expressed in oocytes and embryos are well conserved during evolution.
Significance: Our database and findings provide fundamental resources for understanding the genetic network controlling
early human development.
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Introduction
Preimplantation development is the first step of individual life in
mammals. It includes a series of important developmental events:
final maturation of the oocyte, fertilization, oocyte to zygote
transition,cellproliferationanddifferentiation,andformationofthe
blastocyst. The molecular basis of human preimplantation devel-
opment is not well known, due to the scarce availability of oocytes
and embryos for research. Most available knowledge is based on
mouse [1,2] or bovine [3,4], and limited data comes from non-
human primates (http://www.preger.org/). During the preimplan-
tation phase of mammalian development, cells undergo dramatic
changes. Although recent technology advances have made it
possible to explore the global gene expression profiles from limited
amount of material, no one has systematically explored such
changes in humans. Transcription profiles of only small numbers of
oocytes and embryos have been reported [5–8], reflecting largely
the genetic profiles of individual oocytes and embryos.
In this study we thoroughly dissected more generalizable
transcription profiles of large numbers of pooled morphologically
normal human oocytes and embryos at six different developmental
stages.
Results and Discussion
Overview of the transcriptome during preimplantation
development: two main transitions
The majority of the probe sets did not show statistically
significant change in gene expression between developmental
stages. Only 15% probe sets were up- or down regulated between
stages (p,0.05). Over 80% of the differentially expressed probe
sets fell into two transitions: from MII to D2 and from D3 to D5.
Based on the number of the probe sets, the largest transition
occurred between D3 to D5 (5477 probe sets), and the second
largest between MII and D2 (2989 probe sets). 1508 probe sets
were differentially expressed between D2–D3. There were no
significant expression differences between the developmental
stages of oocytes (GV, MI, MII) (Fig. 1). Using information from
all developmental stages, we could cluster time series of expression
levels (or sequential expression patterns) into 26 patterns (Tables
S1, S16).
In the D3–D5 transition, a group of 2299 probe sets (pattern 2)
were more highly expressed in D5. Gene ontology (GO, Table
S18) analysis showed that these genes are significantly involved in
lipid metabolic process (p-value=10e29), acid metabolic process
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lue=10e24) (Table S2). The higher expression of lipid metabo-
lism in blastocysts has also been found in mice [9]. It may be
related to increased cell proliferation in blastocysts, where more
membrane is needed for newly forming cells. Further, the genes
that had lower expression in D5 (pattern 3, 1715 probe sets) were
more likely involved in transcription (p=10e29), regulation of
nucleic acid metabolism (p=10e29), regulation of transcription
(p=10e28), and spermatogenesis (p=10e26) (Table S3). Several
well-known maternal genes were found in this set: GDF9, BMP6,
ZP1, ZP2, ZP4, POMZP3, ZAR1, NLRP5 (also known as MATER)
and FIGLA. In mice, zona pellucida transcripts decrease
dramatically already in D2 [1]. In our study, significant decreases
of the expression of these genes were observed in D5. ZAR1 and
NALP5 have been found necessary for early embryonic develop-
ment in mice [10,11]. Although their expression decreased earlier
in mice than what we observed regarding the corresponding genes
in human, their function in early human development may be
similar.
The transition from MII to D2 consisted of 1164 probe sets with
decreasing expression (pattern 4) and 691 probe sets with
increasing expression (pattern 5) (Table S4 and S5). The functional
assignment of the genes with decreasing expression by GO
clustered them in the processes of localization (p-value=10e24)
(Table S4, S 18). More than 70% of these transcripts were not
expressed in morphologically normal human sperm (unpublished
data), suggesting that they were more likely to be maternal
transcripts. The proteins produced by the more highly expressed
genes in the MII-D2 transition were mainly localized in nucleus (p-
value=10e212) and ribosomes (p-value=10e26). GO analysis
suggested that they participated in RNA processing (p-va-
lue=10e27), mRNA metabolism (p-value=10e27), and RNA
splicing (p-value=10e28), possibly by binding RNA, or through
their helicase activity (Table S5, S18). The transcriptome
dynamics during MII-D2 transition fits well with the biological
transition from maternal genome to zygote genome, so called
MZT. MZT has been earlier, using more sporadic samples,
estimated to occur around D2 and D3 in humans, and it is
characterized by the activation of zygote genome and the
degradation of maternal mRNA. Hence, it is comprehensible that
RNA processing was highly expressed during MZT. Correspond-
ing analyses for the enrichment in cellular compartments at the
different transitions are presented in Tables S6, S7, S8, S9.
As a conclusion from all the analyzed patterns, we noticed a
dramatic re-programming of transcription and translation during
preimplantation development in a stage-specific manner. In the
D2–D3 and D3–D5 transition, the number of transcripts that had
increasing or decreasing expression was approximately the same.
However, in the MII-D2 transition, more transcripts had
decreasing expression than increasing expression (Table S1). This
‘‘unbalance’’ may due to the large scale degradation of maternal
transcripts and lower number of newly activated transcripts during
this stage, as also found in mice [1].
Difference in the transcriptome between oocytes/
embryos and adult tissue: autonomous preimplantation
development
We also looked at the special character of the transcriptome in
human oocytes and embryos by comparing our data with the
profiles of human healthy adult tissue downloaded from a public
database (http://www.ebi.ac.uk/arrayexpress/, E-AFMX-11).
The database is generated from five tissue types: brain, kidney,
heart, testis and liver (6 biological replicates each) using
hgU133plus2 arrays. All the 30 tissues arrays were pooled together
to represent an average adult expression level. 9,910 probe sets
were expressed at a higher level in oocyte/embryo than in adult
tissue, while 23,134 were expressed in at a lower level in oocyte/
embryo than in adult tissue (Table S10).
The more adult-specific probe sets were enriched for GO
processes regulating signaling and cell communication (Fig. 2,
Table S11): G-protein coupled receptor protein signaling pathway
(p-value=e215), cell communication (p-value=e211), immune
response (p-value=e29), response to external stimulus (p-
value=e28), cell adhesion (p-value=e27), sensory perception
(p-value=e24), cell surface receptor linked signal transduction (p-
value=e24). The significant underrepresentation of transcripts
responsible for cell signaling and communication in oocytes and
embryos indicated that human preimplantation development is
almost self-directed. Hence, oocytes and early embryos proved to
be self-sufficient for developmental programming before implan-
tation because they apparently need not communicate with
‘‘outside world’’, not at least with similar signaling mechanisms
as the cells in adult tissues do. Our proposal supports the ‘‘quiet
embryo hypothesis’’ indicated by Leese’s group [12] who found
that human preimplantation embryos have a relatively low level of
metabolism. The implanted embryos take in significantly less
pyruvate than those failed to implant [13–15]. In addition, the
success of in vitro fertilization (IVF) in humans also supports our
observation of autonomous development [16,17]. The medium
used for IVF is relatively simple and it only supplies the basic needs
for cell metabolism without other special factors encountered in
vivo. However, the oocytes and embryos are competent of
development as in vivo and lead to healthy newborns worldwide.
In contrast to the adult-specific transcripts, the oocyte/embryo-
specific transcripts were enriched for the GO terms biopolymer
metabolism process (p-value=e276), transcription (p-value=e239),
RNA biosynthetic process (p-value=e236), nucleobase, nucleoside,
nucleotide and nucleic acid metabolic process (p-value=e233),
regulation of cellular process (p-value=e224) (Table S12). If we
narrow down this ‘‘oocyte/embryo specific’’ list by looking at those
that were more than five times higher expressed in oocyte and/or
Figure 1. Differentially expressed probe sets between consec-
utive developmental stages.
doi:10.1371/journal.pone.0007844.g001
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mitotic cell cycle (p-value=e212), M phase (p-value=e211),
mitosis (p-value=e211), cell division (p-value=e29), interphase
(p-value=e23), and spindle organization and biogenesis
(p-value=e23). These results are consistent with the notion that
cell proliferation is more active during embryonic development than
in adult tissues. The corresponding cellular component enrichment
analyses are shown in Tables S13–S14.
Evolution signatures of the predominated genes in
oocytes/embryos: the ‘‘preimplantation genes’’ are
generally well conserved
We further characterized the genes that were more highly
expressed in human oocytes and embryos when compared with
adult tissues, by analyzing the evolution signatures of these genes.
We used the Biomart database to access probe specific non-
synonymous (dn) to and synonymous (ds) substitution rates
between humans, chimps, mice and dogs. The ratio dn/ds
measures the selection pressure over coding mutations: a dn/
ds=1, dn/ds,1 and dn/ds.1 imply neutral, negative and
positive selection, respectively. Probes that were more highly
expressed in oocytes and embryos showed on the average a dn/ds
approximately 15% smaller than probes being more highly
expressed in the adult tissue in all the three species (p-values
between 10e220 and 10e230) (Fig. 3d), indicating a stronger
selection pressure against coding mutations for these genes. The
good conservation of these ‘‘preimplantation genes’’ obviously
contributes to the continuous generation of new individuals in the
four species. It has been shown that genes involved in
gametogenesis tend to be under positive selection [18,19]. Our
results suggest that, not only gametogensis genes, but most genes
predominantly expressed during preimplantation development are
well conserved. These ‘‘preimplantation genes’’ are of particular
interest in the field of reproductive evolution.
Specific interesting gene: transcription factor Nr2f2
In order to highlight interesting transcription factors that may
be active in the embryo development, we made a correspondence
analysis between probe set expression and the motifs at the binding
sites of the promoter of the genes they interrogate [20]. The
transcription factor Nr2f2 was found between 3- and 5-fold more
highly expressed at D5. Among the probe sets differentially
regulated at D5, there was a significant overrepresentation of those
harboring the binding site for Nr2f2 (p-val ,10
24). Nr2f2 has
been recently shown to mediate progesterone regulation of uterine
implantation [21]. The Nr2f2-null mutant mice die during the
early embryonic development due to defects in angiogenesis and
heart development [22]. Heterozygote (Nr2f2 +/2) females show
Figure 2. Biological Process Gene Ontology (GO) terms underrepresented in oocytes and embryos when compared with adult
tissues. Colors indicate the significance (p-value) of the underrepresentation.
doi:10.1371/journal.pone.0007844.g002
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puberty, and retarded postnatal growth, possibly because of
reduced production of progesterone and impaired uterine
endometrial functions. Homozygous adult female mutants with
specific inactivation of the Nr2f2 in uterine have severely impaired
placental formation, leading to miscarriage at days 10–12 of
pregnancy [23].
Comparison of the transcriptome between D5 embryos
and stem cell: developmental process related genes are
more highly expressed in D5 embryos
Finally, to further characterize the expression profile of D5, we
compared our arrays with embryonic stem cell (ESC) lines
previously arrayed on HG-U133plus2 [24]. Large overrepresen-
tation of genes annotated to developmental process (p-
value=e24), multicellular organismal processes (p-value=e24),
system development (p-value=e23), blood vessel development (p-
value=e23), organ morphogenesis (p-value=e23) and brain
development (p-value=e23) was found among genes that were
expressed at higher level in D5 embryos than in embryonic stem
cells (Table S15, S16, S17). This suggested that genes regulating
implantation, placenta formation and further embryo develop-
ment were active already at the blastocyst stage. Although stem
cells are generated from inner cell mess of blastocyst, it seemed
that the genes responsible for further embryo development had
lower expression in stem cells. This could be explained by the
routine supplementary of differentiation inhibitors in the culture
medium.
The only ethically acceptable manner to obtain large enough
numbers of human oocytes for this type of a study was to use the GV
and MI oocytes which cannot be injected with sperm, and mature
them in vitro. It may be that some oocytes were abnormal. They may
also just be from a cohort which is at a later developmental stage by the
time of initiation of the gonadotrophin stimulation. The fact that we
Figure 3. Dn/ds distribution for chimp (a), dog (b) and mice (c) for the probe sets interrogated by the HG-U133plus2 arrays. Positive
selection signature can be observed in the chimp on the right side of the histogram. (d) Comparison of dn/ds for the chimp between embryo/oocyte
specific and adult tissue specific probes. Testing the difference between the distributions with a nonparametric (Mann-Whitney) test yields a median
shift of about 15% with a two-tailed significance p-value 10e216.
doi:10.1371/journal.pone.0007844.g003
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some clinical situations MII oocytes are not available, and we can
utilize such in vitro matured oocytes for treatment, resulting in the birth
of healthy infants. There may be some differences in the gene
expression of in vivo and in vitro matured oocytes bur that difference
may be small as predicted from the overall small changes during oocyte
maturation. A few embryos that had not been used for clinical
treatment may also have been somehow abnormal, but we did not use
developmentally retarded embryos. The embryos which were frozen
after the initial transfer and then not needed in treatment, were actually
all of very good quality. It would have been optimal to use only good
quality embryos, but that was not feasible or ethically acceptable.
Minor deviations in this material may be due to the nature of our
starting material, but systematic biases are unlikely as individual
embryos were unlikely to have consequently similar deviations.
Some bias in the result might follow from the potentially
different lengths of poly-A tails in the oocyte RNA and newly
transcribed embryo RNA and subsequent difference in the
efficiency of poly-T priming and reverse transcription. Such a
major bias is however unlikely considering the observation that
roughly similar numbers of transcripts were recorded at different
stages of development, suggesting that a broad set of transcripts
present at all stages were primed.
In summary, we show new original data obtained by genome
wide analysis of in vitro matured human oocytes and embryos,
revealing the almost autonomous maturation of human oocytes and
early embryogenesis. We could also confirm many earlier findings
based on smaller numbers of samples. Our finding and database
provide a fundamental resource for the better understanding of the
complex genetic network that controls early human development.
Materials and Methods
We have had an exceptional opportunity to penetrate into the
earliest events in human life by collecting, as donations for
research, both large numbers of immature oocytes and preim-
plantation human embryos which were not used in the infertility
treatment of the couples. We had ethical approval for this study
from the ethics committees of Karolinska Institutet and O ¨ rebro
University, Sweden. All the donating couples, who were not
reimbursed, gave their informed written consent for the donation
of the immature oocytes and supernumerary embryos (Support-
ing file S1: Materials and Methods, Figures S1, S2, S3, S4, S5,
S6, S7).
A total of 203 in vitro matured oocytes and 194 embryos were
used. The six developmental stages (Fig. 4A) include fully-grown
germinal vesicle oocyte (GV), metaphase I oocyte (MI), metaphase
II oocyte (MII), 4-cell embryo (D2), 8-cell embryo (D3), and
blastocyst (D5). The MII oocytes had been matured in vitro after
donation at GV stage. D2, D3, D5 embryos were all matured in
vitro. For each stage, we pooled 26–43 oocytes or embryos into one
biological sample for RNA extraction and expression profiling
(Fig. 4, Supporting file S1, Figures S1–S3). Two independent
biological samples for each stage were used as replicates.
Complementary DNA was amplified, and labeled according to
the Affymetrix two-cycle GeneChipH Eukaryotic small sample
target labeling assay (version II). The Affymetrix chip HG-U133
Plus 2.0 was used for hybridization. It was not technically feasible
to make triplicates form this sparsely available material.
Data quality was assessed according to Affymetrix guidelines and
benchmarks using software from the Bioconductor bundle (www.
bioconductor.org). (Fig. 4B, Supporting online material: Materials
and Methods, Figures S1, S2). To control experimental variation, the
invariant set normalization method was used and expression values
were extracted from PM-values using the Li-Wong method [25], in
an implementation of the dChip software in R (Figure S3) [26].
Analysis of differential expression between consecutive developmen-
tal stages was performed using a Bayesian approach [27,28] as
implemented in the Limma package (www.bioconductor.org). To
further characterize the pre-implantation stages, we compared those
to human adult tissues hybridized still on HG-U133plus2 arrays. To
account for the technical difference between adult human tissues and
oocytes/embryos, the respective arrays were normalized indepen-
dently, rescaled to the same median intensity and the Li-Wong
method was applied to all the normalized arrays together to get
summary expression measurements (http://biosun1.harvard.edu/
complab/dchip/). Differential expression P-values reported were
corrected for multiple testing using the FDR method.
Supporting Information
Supporting File S1
Found at: doi:10.1371/journal.pone.0007844.s001 (0.05 MB
DOC)
Table S1 Regulation patterns for the oocyte and embryo
maturation. The numbers +1 and 21 indicate either upregulation
or downregulation between consecutive stages
Figure 4. Morphology of human oocytes and embryos used in the study. B. Correlations between biological duplicates.
doi:10.1371/journal.pone.0007844.g004
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XLS)
Table S2 Biological Process enrichment analysis for regulation
pattern 2. P-value is the significance of the enrichment, Bonf is the
P-value corrected for Bonferroni. Size is the number of probesets,
count the number of probesets annotated for the relative GO term
and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s003 (0.02 MB
XLS)
Table S3 Biological Process enrichment analysis for regulation
pattern 3. P-value is the significance of the enrichment, Bonf is the
P-value corrected for Bonferroni. Size is the number of probesets,
count the number of probesets annotated for the relative GO term
and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s004 (0.02 MB
XLS)
Table S4 Biological Process enrichment analysis for regulation
pattern 3. P-value is the significance of the enrichment, Bonf is the
P-value corrected for Bonferroni. Size is the number of probesets,
count the number of probesets annotated for the relative GO term
and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s005 (0.02 MB
XLS)
Table S5 Biological Process enrichment analysis for regulation
pattern 5. P-value is the significance ofthe enrichment, Bonf is the
P-value corrected for Bonferroni. Size is the number of probesets,
count the number of probesets annotated for the relative GO term
and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s006 (0.02 MB
XLS)
Table S6 Cellular Component enrichment analysis for regula-
tion pattern 2. P-value is the significance of the enrichment, Bonf is
the P-value corrected for Bonferroni. Size is the number of
probesets, count the number of probesets annotated for the
relative GO term and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s007 (0.02 MB
XLS)
Table S7 Cellular Component enrichment analysis for
regulation pattern 3. P-value is the significance of the
enrichment, Bonf is the P-value corrected for Bonferroni. Size
is the number of probesets, count the number of probesets
annotated for the relative GO term and ExpCount the number
expected
Found at: doi:10.1371/journal.pone.0007844.s008 (0.01 MB
XLS)
Table S8 Cellular Component enrichment analysis for
regulation pattern 4. P-value is the significance of the
enrichment, Bonf is the P-value corrected for Bonferroni. Size
is the number of probesets, count the number of probesets
annotated for the relative GO term and ExpCount the number
expected
Found at: doi:10.1371/journal.pone.0007844.s009 (0.01 MB
XLS)
Table S9 Cellular Component enrichment analysis for regula-
tion pattern 5. P-value is the significance of the enrichment, Bonf is
the P-value corrected for Bonferroni. Size is the number of
probesets, count the number of probesets annotated for the
relative GO term and ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s010 (0.02 MB
XLS)
Table S10 Comparison of oocytes/embryo with pooled adult
tissues. The numbers +1 and 21 indicate either upregulation or
downregulation between the samples
Found at: doi:10.1371/journal.pone.0007844.s011 (0.01 MB
XLS)
Table S11 Biological Process enrichment analysis for oocytes/
embryo to adult tissues comparison, pattern 1. P-value is the
significance of the enrichment, Bonf is the P-value corrected for
Bonferroni. Size is the number of probesets, count the number of
probesets annotated for the relative GO term and ExpCount the
number expected
Found at: doi:10.1371/journal.pone.0007844.s012 (0.03 MB
XLS)
Table S12 Biological Process enrichment analysis for oocytes/
embryo to adult tissues comparison, pattern 3. P-value is the
significance of the enrichment, Bonf is the P-value corrected for
Bonferroni. Size is the number of probesets, count the number of
probesets annotated for the relative GO term and ExpCount the
number expected
Found at: doi:10.1371/journal.pone.0007844.s013 (0.03 MB
XLS)
Table S13 Cellular Component enrichment analysis for oo-
cytes/embryo to adult tissues comparison, pattern 1. P-value is the
significance of the enrichment, Bonf is the P-value corrected for
Bonferroni. Size is the number of probesets, count the number of
probesets annotated for the relative GO term and ExpCount the
number expected
Found at: doi:10.1371/journal.pone.0007844.s014 (0.02 MB
XLS)
Table S14 Cellular Component enrichment analysis for oo-
cytes/embryo to adult tissues comparison, pattern 3. P-value is the
significance of the enrichment, Bonf is the P-value corrected for
Bonferroni. Size is the number of probesets, count the number of
probesets annotated for the relative GO term and ExpCount the
number expected
Found at: doi:10.1371/journal.pone.0007844.s015 (0.01 MB
XLS)
Table S15 Biological Process enrichment analysis for oo-
cytes/embryo to stem cells comparison. P-value is the
significance of the enrichment, Bonf is the P-value corrected
for Bonferroni. Size is the number of probesets, count the
number of probesets annotated for the relative GO term and
ExpCount the number expected
Found at: doi:10.1371/journal.pone.0007844.s016 (0.01 MB
XLS)
Table S16 Affymetrix transcripts at different stages
Found at: doi:10.1371/journal.pone.0007844.s017 (6.21 MB
XLS)
Table S17 Affymetrix transcripts at different stages, part II
Found at: doi:10.1371/journal.pone.0007844.s018 (4.89 MB
XLS)
Table S18 Gene ontology cathegories
Found at: doi:10.1371/journal.pone.0007844.s019 (2.73 MB
ZIP)
Figure S1 Figure S1 QC, Spikes-In and RNA degradation plots
Found at: doi:10.1371/journal.pone.0007844.s020 (9.93 MB TIF)
Figure S2 Intensities for raw data (a) and (b) and for the
normalized data (c)
Found at: doi:10.1371/journal.pone.0007844.s021 (9.93 MB TIF)
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clustering of the arrays (left) based on the Pearson correlation
coefficient
Found at: doi:10.1371/journal.pone.0007844.s022 (8.87 MB TIF)
Figure S4 Correlation between replicates. The expression values
of the repilcates (in log2 scale) are plotted against each other
Found at: doi:10.1371/journal.pone.0007844.s023 (1.40 MB TIF)
Figure S5 High and low expressed probe sets for p-value=0.05
(left), p-value=0.005 (center) and p-value=0.0005 (right). Yellow
bars represent the number of probe sets with lower expression, the
orange those with higher expression and the red ones the sum of
the two
Found at: doi:10.1371/journal.pone.0007844.s024 (9.93 MB TIF)
Figure S6 High and low expressed probe sets for p-value=0.05
(left), p-value=0.005 (center) and p-value=0.0005 (right). Yellow
bars represent the number of probe sets with lower expression, the
orange those with higher expression and the red ones the sum of
the two.
Found at: doi:10.1371/journal.pone.0007844.s025 (9.93 MB TIF)
Figure S7 Differential expression in mice. Yellow bars represent
the number of probe sets with lower expression, the orange those
with higher expression and the red ones the sum of the two.
Found at: doi:10.1371/journal.pone.0007844.s026 (6.75 MB TIF)
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